Viking Therapeutics Inc (VKTX)
76.56
-3.01
(-3.78%)
USD |
NASDAQ |
May 01, 15:44
Viking Therapeutics Accounts Payable (Quarterly): 5.225M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 5.225M |
December 31, 2023 | 7.512M |
September 30, 2023 | 5.711M |
June 30, 2023 | 5.611M |
March 31, 2023 | 3.799M |
December 31, 2022 | 8.529M |
September 30, 2022 | 3.142M |
June 30, 2022 | 6.104M |
March 31, 2022 | 3.119M |
December 31, 2021 | 1.444M |
September 30, 2021 | 2.852M |
June 30, 2021 | 4.21M |
March 31, 2021 | 4.848M |
December 31, 2020 | 3.988M |
September 30, 2020 | 2.756M |
June 30, 2020 | 3.209M |
March 31, 2020 | 3.098M |
December 31, 2019 | 2.431M |
September 30, 2019 | 2.095M |
June 30, 2019 | 1.87M |
Date | Value |
---|---|
March 31, 2019 | 1.676M |
December 31, 2018 | 0.959M |
September 30, 2018 | 1.215M |
June 30, 2018 | 1.493M |
March 31, 2018 | 0.658M |
December 31, 2017 | 1.529M |
September 30, 2017 | 1.556M |
June 30, 2017 | 1.305M |
March 31, 2017 | 1.727M |
December 31, 2016 | 1.204M |
September 30, 2016 | 0.8813M |
June 30, 2016 | 1.206M |
March 31, 2016 | 1.172M |
December 31, 2015 | 0.5924M |
September 30, 2015 | 0.4017M |
June 30, 2015 | 1.008M |
March 31, 2015 | 1.879M |
December 31, 2014 | 1.831M |
June 30, 2014 | 1.416M |
March 31, 2014 | 0.3792M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
1.444M
Minimum
Dec 2021
8.529M
Maximum
Dec 2022
4.078M
Average
3.504M
Median
Accounts Payable (Quarterly) Benchmarks
Eli Lilly and Co | 2.599B |
Pfizer Inc | 6.71B |
Madrigal Pharmaceuticals Inc | 28.04M |
Akero Therapeutics Inc | 7.038M |
Terns Pharmaceuticals Inc | 2.515M |